SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GMED - GenoMed Inc.
GMED 83.90+36.0%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jmhollen who wrote (178)9/5/2004 11:17:09 PM
From: Tadsamillionaire   of 347
 
GenoMed Names Dr. Dennis Robbins as Chairman of Its Newly Created Business Advisory Board
Wednesday August 25, 9:32 am ET

ST. LOUIS, Aug. 25 /PRNewswire-FirstCall/ -- GenoMed, Inc. (Pink Sheets: GMED - News), a Next Generation DM(TM) (Disease Management) company that uses its expertise in genomics to improve clinical outcomes, announced today that it has named Dr. Dennis A. Robbins as Chairman of its newly created Business Advisory Board. Dr. Robbins is a national expert in ethics and clinical reimbursement.
Since its inception, GenoMed has had a Scientific Advisory Board composed of distinguished scientists and physicians. The Company is now establishing a Business Advisory Board to guide it in transforming medicine from a hospital-based business to an outpatient, preventive profession.

According to Dr. David Moskowitz, GenoMed's Chairman and CEO, "The business, and ethics, of what we're trying to do are at least as complex as the science."

Dennis A. Robbins Ph.D., M.P.H. has been an active force in shaping various national health care agendas. He is a well respected speaker, advisor and center of influence. His ideas have been aired or written about nationally showcasing his innovative and cutting edge approaches to the development and adoption of new ideas, technologies and strategies for change. He has extensive experience in ethics with a Ph.D. in Philosophy from Boston College complemented by a postdoctoral MPH at Harvard. Besides his postdoctoral training as a National Fund for Medical Education Fellow in the Kennedy Interfaculty Program in Medical Ethics at Harvard he also served as a Visiting Scholar and Research Fellow in Medical Ethics in the Harvard School of Public Health. He has worked as an advisor and ethics consultant in many sectors of the health care field. He has been a director of medical ethics in hospitals, an advisor to the President's Commission on Ethics in Biomedicine and Biomedical Research, served on the Michigan Transplantation Committee, and was an advisor to the Ministry of Health in the Soviet Far East. Dr Robbins has held numerous academic and medical school appointments. He has authored eight books on medical ethics and over 250 articles, chapters and reviews dealing with healthcare ethics. He was recently honored as among the top ten keenest thinkers in Managed Care by Managed Health Care Executive magazine. He serves on several national advisory and editorial boards building upon his former work with Time/Life.

biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext